Intravenous lacosamide in refractory seizure clusters and status epilepticus: Comparison of 200 and 400 mg loading doses

Neurocritical Care

Volumn 20, Issue 3, 2014, Pages 484-488

  Legros, Benjamin ^a   Depondt, Chantal ^a   Levy Nogueira, Marcel ^a   Ligot, Noémie ^a   Mavroudakis, Nicolas ^a   Naeije, Gilles ^a   Gaspard, Nicolas ^a,b  

^a ERASME HOSPITAL   (Belgium)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anticonvulsant; Lacosamide; Refractory status epilepticus; Seizure clusters; Treatment

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTICONVULSIVE AGENT; ASPARTATE AMINOTRANSFERASE; CARBAMAZEPINE; DIAZEPAM; ETIRACETAM; HARKOSERIDE; KETAMINE; LORAZEPAM; MIDAZOLAM; PHENOBARBITAL; PHENYTOIN; PREGABALIN; PROPOFOL; STEROID; THIOPENTAL; TOPIRAMATE; VALPROIC ACID; ACETAMIDE DERIVATIVE;

ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; ATAXIA; CARDIOTOXICITY; CARDIOVASCULAR DISEASE; CONFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG ERUPTION; DRUG SAFETY; EPILEPTIC STATE; FEMALE; HEMODYNAMICS; HUMAN; LIVER TOXICITY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MYOCLONUS; NEPHROTOXICITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; REFRACTORY STATUS EPILEPTICUS; SEIZURE; TREATMENT RESPONSE; VERTIGO; ADOLESCENT; COMPARATIVE STUDY; DRUG RESISTANCE; INTENSIVE CARE; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; STATUS EPILEPTICUS; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ACETAMIDES; ADMINISTRATION, INTRAVENOUS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; FEMALE; HUMANS; INTENSIVE CARE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; STATUS EPILEPTICUS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84902377143     PISSN: 15416933     EISSN: 15560961     Source Type: Journal    
DOI: 10.1007/s12028-013-9882-6     Document Type: Article

References (18)

1. Meierkord H, Boon P, Engelsen B, et al. EFNS guideline on the management of status epilepticus in adults. Eur J Neurol. 2010;17:348-55.
2. Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17(1):3-23.
3. Hocker SE, Britton JW, Mandrekar JN, Wijdicks EFM, Rabinstein AA. Predictors of outcome in refractory status epilepticus. Arch Neurol. 2012;8:1-6.
4. Kowalski RG, Ziai WC, Rees RN, et al. Third-line antiepileptic therapy and outcome in status epilepticus: the impact of vasopressor use and prolonged mechanical ventilation. Crit Care Med. 2012;40(9):2677-84.
5. Alvarez V, Januel JM, Burnand B, Rossetti AO. Second-line status epilepticus treatment: comparison of phenytoin, valproate, and levetiracetam. Epilepsia. 2011;52(7):1292-6.
6. Albers JM, Moddel G, Dittrich R, et al. Intravenous lacosamide - an effective add-on treatment of refractory status epilepticus. Seizure. 2011;20(5):428-30.
7. Rantsch K, Walter U, Wittstock M, Benecke R, Rosche J. Efficacy of intravenous lacosamide in refractory nonconvulsive status epilepticus and simple partial status epilepticus. Seizure. 2011;20(7):529-32.
8. Parkerson KA, Reinsberger C, Chou SH, Dworetzky BA, Lee JW. Lacosamide in the treatment of acute recurrent seizures and periodic epileptiform patterns in critically ill patients. Epilepsy Behav. 2011;20(1):48-51.
9. Koubeissi MZ, Mayor CL, Estephan B, Rashid S, Azar NJ. Efficacy and safety of intravenous lacosamide in refractory nonconvulsive status epilepticus. Acta Neurol Scand. 2011;123(2):142-6.
10. Kellinghaus C, Berning S, Immisch I, et al. Intravenous lacosamide for treatment of status epilepticus. Acta Neurol Scand. 2011;123(2):137-41.
11. Hofler J, Unterberger I, Dobesberger J, Kuchukhidze G, Walser G, Trinka E. Intravenous lacosamide in status epilepticus and seizure clusters. Epilepsia. 2011;52(10):e148-52.
12. Goodwin H, Hinson HE, Shermock KM, Karanjia N, Lewin JJ III. The use of lacosamide in refractory status epilepticus. Neurocrit Care. 2011;14(3):348-53.
13. Jain V, Harvey AS. Treatment of refractory tonic status epilepticus with intravenous lacosamide. Epilepsia. 2012;53(4):761-2.
14. Mnatsakanyan L, Chung JM, Tsimerinov EI, Eliashiv DS. Intravenous lacosamide in refractory nonconvulsive status epilepticus. Seizure. 2012;21(3):198-201.
15. Cherry S, Judd L, Muniz JC, Elzawahry H, LaRoche S. Safety and efficacy of lacosamide in the intensive care unit. Neurocrit Care. 2012;16(2):294-8.
16. Höfler J, Trinka E. Lacosamide as a new treatment option in status epilepticus. Epilepsia. 2013;54(3):393-404.
17. Young GB, Jordan KG, Doig GS. An assessment of nonconvulsive seizures in the intensive care unit using continuous EEG monitoring: an investigation of variables associated with mortality. Neurology. 1996;47(1):83-9. (Pubitemid 26243864)
18. Belcastro V, Arnaboldi M, Taborelli A, Prontera P. Induction of epileptic negative myoclonus by addition of lacosamide to carbamazepine. YEBEH. 2011;20(3):2.